Literature DB >> 17609628

Squamous cell carcinoma of the tongue in a 13-year-old girl with Fanconi anemia.

Harald Reinhard1, Isabelle Peters, Sven Gottschling, Wolfram Ebell, Norbert Graf.   

Abstract

We report the case of a 13-year-old girl with squamous cell carcinoma (SCC) of the tongue. Fanconi anemia with a yet unknown complementation group had been diagnosed at the age of 5 years. Organ involvement included intestinal atresia, renal dysfunction due to crossed renal atopia, and tubular acidosis type II. Because of repeated bleeding complications frequent transfusions, and severe infections, bone marrow transplantation (BMT) from a matched unrelated donor was done at the age of 11 years. The girl did not suffer from graft-versus-host disease and had complete hematologic reconstitution after transplantation. Two years after BMT a SCC of the tongue developed without nodal or systemic metastasis. The tumor could be completely resected and no functional disturbances remained. No further treatment was given and the patient is in complete remission 6 months after diagnosis. This is one of the youngest children reported with SCC of the tongue after BMT for Fanconi anemia so far.

Entities:  

Mesh:

Year:  2007        PMID: 17609628     DOI: 10.1097/MPH.0b013e318063ef14

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

Review 1.  Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.

Authors:  K Scheckenbach; M Wagenmann; M Freund; J Schipper; H Hanenberg
Journal:  Klin Padiatr       Date:  2012-04-13       Impact factor: 1.349

2.  Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-07

3.  Outcomes of oral cavity squamous cell carcinoma in pediatric patients.

Authors:  Luc G T Morris; Ian Ganly
Journal:  Oral Oncol       Date:  2010-02-25       Impact factor: 5.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.